Mapol will be hosting a Private Payer PLAs Seminar on Wednesday June 8, 2016 from 8AM – 12PM noon at the Hilton Garden Inn, Toronto/Brampton.  Registration Deadline: Friday June 3, 2016! This is a closed-door seminar for invited brand pharmaceutical manufacturers. Learn more

Mapol Inc. is pleased to welcome Lara Dangourian to the Mapol Team. Lara’s role is Manager, Market Access. Lara has over eight years of experience in the pharmaceutical industry. Her experience with HTA submissions and her detailed knowledge of processes will provide value to Mapol's clients in the preparation of new product submissions (or re-submissions). Based in Montréal, Lara will be supporting brand pharmaceutical manufactures within a wide range of market access activities. Lara holds a Master of Science degree in Drug Development from Université de Montréal.

TORONTO, Dec. 22, 2015 /CNW/ - In 2014 the cost of covering highly expensive and recurring drug treatments increased by 45% over 2013 for life and health insurance industry benefit plans.  This information was released today by the Canadian Drug Insurance Pooling Corporation (CDIPC), the mechanism under which Canadian life and health insurers voluntarily share the costs of highly expensive and recurring drug treatments. Read More